As the MDA-MB-231 breast cancer cells express all the four subtypes of PGE2 receptors, it remains to be determined whether the biphasic effect of PGE2 on their invasiveness and release of MMP-2 could be related to activation of different subtypes of its receptor. This evidence concerns the gene MMP2 and breast carcinoma.